Determinants of perceived patient benefit in a longitudinal cohort study of patients with psoriasis and atopic dermatitis

Determinants of perceived patient benefit in a longitudinal cohort study of patients with psoriasis and atopic dermatitis

Abstract The Dermatology Life Quality Index (DLQI) should be used to assess treatment success in psoriasis (PSO). However, the DLQI does not assess the importance and achievement of treatment goals. The Patient Benefit Index (PBI) is a questionnaire that takes both into account. Currently, there is...

Full description

Saved in:
Bibliographic Details
Main Authors: Gloria-Beatrice Wintermann, Susanne Abraham, Eva M. J. Peters, Stefan Beissert, Kerstin Weidner
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Psoriasis (PSO)
Atopic dermatitis (AD)
Patient benefit index (PBI)
Dermatology life quality index (DLQI)
Anxiety/depression
Biologics
Online Access:https://doi.org/10.1038/s41598-024-84794-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items